Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

The market is projected to grow from $11B in 2024 to $40B by 2030, driven by both conventional bispecifics and advancements such as antibody-drug ... workflow for monoclonal antibody discovery ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced it has granted Immunome, Inc. (Nasdaq: IMNM) ...

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services ... demonstrated an understanding of evitria’s complex workflow ...

meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into immune responses to disease and identifies targetable biomarkers ...

Under the agreement, UCB gains a non-exclusive license to leverage XtalFold for the discovery and engineering of biologics.

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...